Abbott tacks another extension on Alere tender offer

September 5, 2017 By Fink Densford Leave a Comment

Abbott (NYSE:ABT) said last Friday it is yet again extending a tender offer for all outstanding Alere (NYSE:ALR) Series B convertible perpetual preferred stock shares at $402 per share, pushing the deadline from Aug. 31 to Sept. 15.

As part of the offering, Abbott said it will also pay for unpaid dividends to the settlement date of the tender offer in cash, without interest and subject to applicable taxes.

The offer, originally announced on July 17, is being extended to “allow additional time for the consummation of the merger,” Abbott said in a press release. The offer was originally slated to expire at midnight on August 11, and was previously extended to August 31.

Abbott said that as of Aug. 31, greater than 90% of the issued oustanding shares have been tendered in the offer.

In early July, Alere shareholders voted to approve its amended merger with Abbott. The amended merger was agreed to in April at a $5.3 billion price tag, with Alere shareholders receiving $51 per common share in cash.

Those numbers are down from the original merger agreement, which would have seen Abbott paying $5.8 billion for the company.

A series of accounting snafus, including a significantly delayed Q4 2016 earnings filing and a ban imposed on its Arriva Medical diabetes division by the Centers for Medicare & Medicaid Services led to problems with its pending acquisition by Abbott.

Waltham, Mass.-based Alere said in March that it would miss the deadline for releasing last year’s results due to an investigation of inappropriate conduct at its South Korean Standard Diagnostics subsidiary. It wasn’t the 1st delay for Alere, which belatedly filed its 2015 annual report in August 2016 after finding “immaterial error” in its revenue recognition processes and “material weaknesses” in the way it recognized revenues and accounted for income taxes.

NEW! Technology Track at DeviceTalks Boston

These featured panels at DeviceTalks Boston will explore the state of R&D at major medtech firms, as well as the latest trends when it comes to developing combination products, neuromodulation devices, robotic systems and women's health technology.

View Technology Track Featured Sessions

Register today to save. Use code TECHTRACK to save an additional 10%.

Study: Doctors receiving high compensation fail to disclose relationships with med device firms
Doctors aren’t accurately reporting compensation they receive from medical device companies, according to a new study published in the JAMA Surgery. In the study, researchers performed a bibliometric analysis of the 100 physicians receiving the highest compensation from 10 large surgical and medical device manufacturers using payment data from the Centers for Medicare & Medicaid […]
Vascular Graft Solutions’ aneurysm graft used in hemodialysis patients
Vascular Graft Solutions has reported the first clinical use of its Frame external support technology in high-flow arteriovenous (AV) fistulas. The first five cases were performed by Dr. Vladimir Matoussevitch from Cologne University Hospital in Germany. The braided cobalt chrome, kink-resistant external support was designed for autologous vein grafts in bypass or reconstruction of peripheral arterial […]
Murata to boost MEMS production in Finland
Murata Manufacturing announced it is investing $45 million in the purchase of two factory buildings and the construction of a third to manufacture micro electro mechanical systems (MEMS) sensors in Finland. The Kyoto-based company had been leasing the two buildings it purchased and expects to complete the adjacent 172,000-square-foot factory in Vantaa, Finland, by the end […]
This in-body GPS system could track tumor movement in real-time
Researchers from Massachusetts Institute of Technology’s Computer Science and Artificial Laboratory have developed a wireless system that acts like an in-body GPS, allowing doctors to use sensors to track tumors or dispense drugs. The system, known as the ReMix, is able to pinpoint the location of ingestible implants inside the body by using low-power wireless […]
Medical devices: The transition to connected devices
C&K Cutting Edge Blog #2 By Roger Bohannan – C&K Medical Segment Leader The shift in medical device development from the unconnected device to the connected device is upon us. This shift will make an enormous impact on the quality and effectiveness of medical care over the next decade and beyond. Device design engineers worldwide […]
ValenTx raises $10.3 million for implantable gastric bypass device
Startup ValenTx has attracted nearly $10.3 million from 32 investors, according to a filing with the Securities & Exchange Commission. The Maple Grove, Minn. company is developing a removable gastric bypass device as an alternative to Roux-en-Y gastric bypass surgery. It raised $10,271,050 in the round begun July 18, 2018. The ValenTx endoluminal bypass therapy […]
GW Plastic wins Vermont Business Growth Award and workforce development grants
GW Plastics recently announced that it has won the 2018 Vermont Business Growth Award, as well as two workforce development training grants. The annual Vermont Business Growth Award is presented by the Vermont Business Magazine and KeyBank and acknowledges the top Vermont businesses that have had the greatest growth over the last five years. This […]
FDA clears CoreLink’s new spinal implant
Spinal implant maker CoreLink has landed FDA 510(k) clearance for a new anterior lumbar (ALIF) interbody device. The Foundation 3D ALIF uses the company’s proprietary mimetic metal technology, which mimics natural bone characteristics, including 100% open-pore architecture and micro-roughened porosity with hydro-wicking properties. The new ALIF design also has patent-pending technology that creates a combination of […]
Syneo receives patent in China
Syneo recently received a patent in China for its Servo Electric Press Two-Stage Force technology. The patent gives the company the rights to use its two-stage force measuring system in manual electric press and automatic electric press (press-fit) machine applications. The patent protects the company’s technology that is featured in the two-stage force measuring system […]
FDA approves first generic Epipen
The FDA this week approved the first generic version of Mylan‘s (NSDQ:MYL) Epipen emergency allergy auto-injector. Teva Pharmaceuticals (NYSE:TEVA), which won the historic approval, plans to market the generic epinephrine auto-injector in 0.3mg and 0.15mg doses. There are other epinephrine auto-injectors on the market in the U.S., but Teva’s is the first that’s approved to directly substitute […]
FDA finalizes streamlined bundled, quarterly MDR reporting system
The FDA today announced it finalized its new Voluntary Malfunction Summary Reporting Program intended to streamline medical device manufacturer malfunction reporting. The program was created in part through public comments received by the FDA and is intended to allow manufacturers to report “certain device malfunctions in summary form on a quarterly basis” instead of an […]